Akanda Corp. (AKAN)
USD 1.08
(0.93%)
USD 1.08
(0.93%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.48 Million USD | -85.14% |
| 2022 | 23.44 Million USD | 283.17% |
| 2021 | 6.11 Million USD | 267.27% |
| 2020 | 1.66 Million USD | 84.87% |
| 2019 | 901.23 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.21 Million USD | 0.0% |
| 2023 Q2 | 3.16 Million USD | -3.95% |
| 2023 Q3 | 12.77 Million USD | 303.59% |
| 2023 FY | 3.48 Million USD | -85.14% |
| 2023 Q1 | 3.29 Million USD | -56.58% |
| 2023 Q4 | 1.7 Million USD | -86.66% |
| 2022 Q1 | 547.92 Thousand USD | -71.44% |
| 2022 FY | 23.44 Million USD | 283.17% |
| 2022 Q3 | 6.24 Million USD | 76.23% |
| 2022 Q4 | 7.58 Million USD | 21.52% |
| 2022 Q2 | 3.54 Million USD | 546.56% |
| 2021 Q3 | 4.05 Million USD | 5514.97% |
| 2021 FY | 6.11 Million USD | 267.27% |
| 2021 Q4 | 1.91 Million USD | -52.71% |
| 2021 Q2 | 72.25 Thousand USD | -0.0% |
| 2021 Q1 | 72.25 Thousand USD | -87.92% |
| 2020 Q4 | 598.11 Thousand USD | 0.0% |
| 2020 FY | 1.66 Million USD | 84.87% |
| 2019 FY | 901.23 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | 57.79% |
| Alpha Teknova, Inc. | 45.85 Million USD | 92.404% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 98.223% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 92.234% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 97.812% |
| Cosmos Health Inc. | 26.18 Million USD | 86.694% |
| Journey Medical Corporation | 54.59 Million USD | 93.619% |
| Embecta Corp. | 528.4 Million USD | 99.341% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 98.719% |
| Dynavax Technologies Corporation | 219.14 Million USD | 98.41% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 99.41% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 98.933% |
| PainReform Ltd. | 9.58 Million USD | 63.653% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 73.458% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 73.458% |
| SCYNEXIS, Inc. | 51.84 Million USD | 93.281% |
| Safety Shot Inc | 12.1 Million USD | 71.234% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -13.499% |
| Procaps Group, S.A. | 199.47 Million USD | 98.254% |
| Theratechnologies Inc. | 72.75 Million USD | 95.212% |
| Harrow Health, Inc. | 89.97 Million USD | 96.128% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | 63.122% |
| Biofrontera Inc. | 39.95 Million USD | 91.282% |
| DURECT Corporation | 43.71 Million USD | 92.031% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 99.342% |
| Cronos Group Inc. | 96.7 Million USD | 96.398% |
| OptiNose, Inc. | 85.1 Million USD | 95.907% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 98.499% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 91.103% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 136.435% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 98.891% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | 64.201% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 91.906% |
| Radius Health, Inc. | 265.92 Million USD | 98.69% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 74.834% |
| ProPhase Labs, Inc. | 37.85 Million USD | 90.797% |
| Phibro Animal Health Corporation | 260.29 Million USD | 98.662% |
| Procaps Group S.A. | 187.24 Million USD | 98.14% |
| Alvotech | 285.43 Million USD | 98.78% |
| TherapeuticsMD, Inc. | 9.82 Million USD | 64.544% |
| Viatris Inc. | 5.96 Billion USD | 99.942% |
| Rockwell Medical, Inc. | 15.37 Million USD | 77.342% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 94.179% |
| SIGA Technologies, Inc. | 22.04 Million USD | 84.197% |
| Tilray Brands, Inc. | 251.35 Million USD | 98.614% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 92.896% |
| Shineco, Inc. | 17.94 Million USD | 80.591% |
| PetIQ, Inc. | 192.72 Million USD | 98.192% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | 12.719% |
| Incannex Healthcare Limited | 30.05 Million USD | 88.409% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.782% |
| Alimera Sciences, Inc. | 62.64 Million USD | 94.439% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -356.858% |
| Assertio Holdings, Inc. | 368.58 Million USD | 99.055% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | 40.813% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 80.439% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 83.544% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 83.445% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 97.888% |
| Hempacco Co., Inc. | 7.59 Million USD | 54.143% |
| Talphera, Inc. | 11.99 Million USD | 70.956% |
| Alvotech | 285.43 Million USD | 98.78% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 97.524% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 98.99% |
| Currenc Group, Inc. | 24 Million USD | 85.487% |
| Kamada Ltd. | 45.42 Million USD | 92.331% |
| Indivior PLC | 911 Million USD | 99.618% |
| Evoke Pharma, Inc. | 12.4 Million USD | 71.929% |
| Flora Growth Corp. | 10.57 Million USD | 67.071% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 83.445% |
| Evolus, Inc. | 189.75 Million USD | 98.164% |
| HUTCHMED (China) Limited | 436.23 Million USD | 99.201% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 97.74% |